Naohiro Nishida

5.9k total citations · 1 hit paper
72 papers, 3.6k citations indexed

About

Naohiro Nishida is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Naohiro Nishida has authored 72 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 30 papers in Cancer Research and 24 papers in Oncology. Recurrent topics in Naohiro Nishida's work include Epigenetics and DNA Methylation (13 papers), Cancer, Hypoxia, and Metabolism (12 papers) and MicroRNA in disease regulation (11 papers). Naohiro Nishida is often cited by papers focused on Epigenetics and DNA Methylation (13 papers), Cancer, Hypoxia, and Metabolism (12 papers) and MicroRNA in disease regulation (11 papers). Naohiro Nishida collaborates with scholars based in Japan, United States and South Korea. Naohiro Nishida's co-authors include Heidi Schwarzenbach, George A. Călin, Klaus Pantel, Masaki Mori, Yuichiro� Doki, Hideshi Ishii, Koshi Mimori, Masamitsu Konno, Koichi Kawamoto and Jun Koseki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Naohiro Nishida

69 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical relevance of circulating cell-free microRNAs in cancer

2014 862 citations Naohiro Nishida, George A. Călin et al. profile →

Peers

Countries citing papers authored by Naohiro Nishida

Since Specialization

Citations

This map shows the geographic impact of Naohiro Nishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naohiro Nishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naohiro Nishida more than expected).

Fields of papers citing papers by Naohiro Nishida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naohiro Nishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naohiro Nishida. The network helps show where Naohiro Nishida may publish in the future.

Co-authorship network of co-authors of Naohiro Nishida

This figure shows the co-authorship network connecting the top 25 collaborators of Naohiro Nishida. A scholar is included among the top collaborators of Naohiro Nishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naohiro Nishida. Naohiro Nishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early detection of brain metastases and appropriate local therapy followed by systemic chemotherapy may improve the prognosis of gastric cancer 2023 ·Scientific Reports ·(unknown), Takeshi Omori, Naoki Shinno, Masaaki Yamamoto, Hisashi Hara, Tomoyuki Otsuka, (unknown), Naohiro Nishida, (unknown), Naotoshi Sugimoto, Toshinari Yagi, Masahiro Goto, Hiroki Nishikawa, Toshihiro Kudo	3
2	Long noncoding RNA 01534 maintains cancer stemness by downregulating endoplasmic reticulum stress response in colorectal cancer 2022 ·Annals of Gastroenterological Surgery ·(unknown), Hidekazu Takahashi, Naohiro Nishida, Cristina Ivan, Daisuke Okuzaki, Yuhki Yokoyama, Masahisa Ohtsuka, Norikatsu Miyoshi, Mamoru Uemura, Shinji Tanaka, George A. Călin, Masaki Mori, Yuichiro� Doki, Hidetoshi Eguchi, Hirofumi Yamamoto	3
3	Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi‐institutional retrospective study 2022 ·Annals of Gastroenterological Surgery ·Takehiro Noda, Hidekazu Takahashi, Mitsuyoshi Tei, Naohiro Nishida, Taishi Hata, Yutaka Takeda, Masayuki Ohue, Hiroshi Wada, Tsunekazu Mizushima, Tadafumi Asaoka, Mamoru Uemura, Shogo Kobayashi, Kohei Murata, Taroh Satoh, Yuichiro� Doki, Hidetoshi Eguchi	10
4	Specific activation of glycolytic enzyme enolase 2 in BRAF V600E‐mutated colorectal cancer 2021 ·Cancer Science ·(unknown), Naohiro Nishida, Tsuyoshi Hata, Shiki Fujino, Takayuki Ogino, Norikatsu Miyoshi, Hidekazu Takahashi, Mamoru Uemura, Taroh Satoh, Hirofumi Yamamoto, Tsunekazu Mizushima, Yuichiro� Doki, Hidetoshi Eguchi	21
5	Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells 2019 ·Cancer Research ·(unknown), Jun Koseki, Hidekazu Takahashi, Norikatsu Miyoshi, Naohiro Nishida, Junichi Nishimura, Taishi Hata, Chu Matsuda, Tsunekazu Mizushima, Hirofumi Yamamoto, Hideshi Ishii, Yuichiro� Doki, Masaki Mori, Naotsugu Haraguchi	51
6	Dysphagia Score as a Predictor of Adverse Events Due to Triplet Chemotherapy and Oncological Outcomes in 434 Consecutive Patients with Esophageal Cancer 2019 ·Annals of Surgical Oncology ·(unknown), Tomoki Makino, Makoto Yamasaki, Koji Tanaka, Naohiro Nishida, Daisuke Sakai, Masaaki Motoori, Yutaka Kimura, Taroh Satoh, Masaki Mori, Yuichiro� Doki	21
7	Gallbladder cancer harboring ERBB2 mutation on the primary and metastatic site: A case report 2019 ·World Journal of Gastrointestinal Oncology ·(unknown), Daichi Maeda, (unknown), (unknown), Yoshifumi Iwagami, Naohiro Nishida, Daisuke Sakai, (unknown), Shinichi Yachida, Yuichiro� Doki, Taroh Satoh	4
8	Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells 2018 ·Scientific Reports ·Masamitsu Konno, Hidetoshi Matsui, Jun Koseki, Ayumu Asai, Yoshihiro Kano, Koichi Kawamoto, Naohiro Nishida, Daisuke Sakai, Toshihiro Kudo, Taroh Satoh, Yuichiro� Doki, Masaki Mori, Hideshi Ishii	4
9	The one-carbon metabolism pathway highlights therapeutic targets for gastrointestinal cancer (Review) 2017 ·International Journal of Oncology ·Masamitsu Konno, Ayumu Asai, Koichi Kawamoto, Naohiro Nishida, Taroh Satoh, Yuichiro� Doki, Masaki Mori, Hideshi Ishii	40
10	MicroRNA miR-374, a potential radiosensitizer for carbon ion beam radiotherapy 2016 ·Oncology Reports ·(unknown), Katsutoshi Sato, Naohiro Nishida, Jun Koseki, (unknown), Koichi Kawamoto, Masamitsu Konno, Kazuhiko Hayashi, Taroh Satoh, Yuichiro� Doki, Masaki Mori, Hideshi Ishii, Kazuhiko Ogawa	15
11	BRAFV600E inhibition stimulates AMP-activated protein kinase-mediated autophagy in colorectal cancer cells 2016 ·Scientific Reports ·Toshinori Sueda, Daisuke Sakai, Koichi Kawamoto, Masamitsu Konno, Naohiro Nishida, Jun Koseki, Hugh Shunsuke Colvin, Hidekazu Takahashi, Naotsugu Haraguchi, Junichi Nishimura, Taishi Hata, Ichiro Takemasa, Tsunekazu Mizushima, Hirofumi Yamamoto, Taroh Satoh, Yuichiro� Doki, Masaki Mori, Hideshi Ishii	38
12	A Trans-omics Mathematical Analysis Reveals Novel Functions of the Ornithine Metabolic Pathway in Cancer Stem Cells 2016 ·Scientific Reports ·Jun Koseki, Hidetoshi Matsui, Masamitsu Konno, Naohiro Nishida, Koichi Kawamoto, Yoshihiro Kano, Masaki Mori, Yuichiro� Doki, Hideshi Ishii	11
13	Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer 2016 ·Scientific Reports ·Masaaki Miyo, Masamitsu Konno, Naohiro Nishida, Toshinori Sueda, Kozo Noguchi, Hidetoshi Matsui, Hugh Shunsuke Colvin, Koichi Kawamoto, Jun Koseki, Naotsugu Haraguchi, Junichi Nishimura, Taishi Hata, Noriko Gotoh, Fumio Matsuda, Taroh Satoh, Tsunekazu Mizushima, Hiroshi Shimizu, Yuichiro� Doki, Masaki Mori, Hideshi Ishii	55
14	Pyruvate kinase M2, but not M1, allele maintains immature metabolic states of murine embryonic stem cells 2015 ·Regenerative Therapy ·Masamitsu Konno, (unknown), Jun Koseki, Nobuhiro Tanuma, Naohiro Nishida, Koichi Kawamoto, Tatsunori Nishimura, Asuka Nakata, Hidetoshi Matsui, (unknown), Miyuki Ozaki, Yuko Noguchi, Hiroshi Shima, Noriko Gotoh, Hiroaki Nagano, Yuichiro� Doki, Masaki Mori	6
15	A crucial epithelial to mesenchymal transition regulator, Sox4/Ezh2 axis is closely related to the clinical outcome in pancreatic cancer patients 2015 ·International Journal of Oncology ·Shinichiro Hasegawa, Hiroaki Nagano, Masamitsu Konno, Hidetoshi Eguchi, Akira Tomokuni, Yoshito Tomimaru, Tadafumi Asaoka, Hiroshi Wada, Naoki Hama, Koichi Kawamoto, Shigeru Marubashi, Naohiro Nishida, Jun Koseki, Masaki Mori, Yuichiro� Doki, Hideshi Ishii	31
16	Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters 2012 ·Clinical Cancer Research ·Naohiro Nishida, Makoto Nagahara, Tetsuya Sato, Koshi Mimori, Tomoya Sudo, Fumiaki Tanaka, Kohei Shibata, Hideshi Ishii, Kenichi Sugihara, Yuichiro� Doki, Masaki Mori	141
17	Expression of Mesenchymal Markers Vimentin and Fibronectin: The Clinical Significance in Esophageal Squamous Cell Carcinoma 2012 ·Annals of Surgical Oncology ·Tomoya Sudo, Takeshi Iwaya, Naohiro Nishida, Genta Sawada, Yusuke Takahashi, Masahisa Ishibashi, Kohei Shibata, Hiromasa Fujita, Kazuo Shirouzu, Masaki Mori, Koshi Mimori	55
18	MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab 2011 ·Clinical Cancer Research ·Naohiro Nishida, Koshi Mimori, Muller Fabbri, Takehiko Yokobori, Tomoya Sudo, Fumiaki Tanaka, Kohei Shibata, Hideshi Ishii, Yuichiro� Doki, Masaki Mori	215
19	Development and evaluation of a monolithic drug-in-adhesive patch for valsartan 2010 ·International Journal of Pharmaceutics ·Naohiro Nishida, (unknown), (unknown), (unknown)	29
20	Significance of Lgr5+ve Cancer Stem Cells in the Colon and Rectum 2010 ·Annals of Surgical Oncology ·Hidekazu Takahashi, Hideshi Ishii, Naohiro Nishida, Ichiro Takemasa, Tsunekazu Mizushima, Masataka Ikeda, Takehiko Yokobori, Koshi Mimori, Hirofumi Yamamoto, Mitsugu Sekimoto, Yuichiro� Doki, Masaki Mori	131

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact